• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有复发性事件的加权复合时间事件终点:三种分析方法的比较。

Weighted composite time to event endpoints with recurrent events: comparison of three analytical approaches.

机构信息

Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Institute of Biometry and Clinical Epidemiology, Charitéplatz 1, Berlin, 10117, Germany.

出版信息

BMC Med Res Methodol. 2022 Feb 5;22(1):38. doi: 10.1186/s12874-022-01511-1.

DOI:10.1186/s12874-022-01511-1
PMID:35123397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8818231/
Abstract

BACKGROUND

In clinical trials the study interest often lies in the comparison of a treatment to a control regarding a time to event endpoint. A composite endpoint allows to consider several time to event endpoints at once. Usually, only the time to the first occurring event for a patient is thereby analyzed. However, an individual may experience more than one non-fatal event. Including all observed events in the analysis can increase the power and provides a more complete picture of the disease. Thus, analytical methods for recurrent events are required. A challenge is that the different event types belonging to the composite often are of different clinical relevance. In this case, weighting the event types according to their clinical relevance is an option. Different weight-based methods for composite time to event endpoints were proposed. So far, there exists no systematic comparison of these methods.

METHODS

Within this work we provide a systematic comparison of three methods proposed for weighted composite endpoints in a recurrent event setting combining non-fatal and fatal events of different clinical relevance. We consider an extension of an approach proposed by Wei and Lachin, an approach by Rauch et al., and an approach by Bakal et al.. Comparison is done based on a simulation study and based on a clinical study example.

RESULTS

For all three approaches closed formula test statistics are available. The Wei-Lachin approach and the approach by Rauch et al. show similar results in mean squared error. For the approach by Wei and Lachin confidence intervals are provided. The approach by Bakal et al. is not related to a quantifiable estimand. The relevance weights of the different approaches work on different level, i.e. either on cause-specific hazard ratios or on event count.

CONCLUSION

The provided comparison and simulations can help to guide applied researchers to choose an adequate method for the analysis of composite endpoints combining (recurrent) events of different clinical relevance. The approach by Wei and Lachin and Rauch et al. can be recommended in scenarios where the composite effect is time-independent. The approach by Bakal et al. should be applied carefully.

摘要

背景

在临床试验中,研究兴趣通常在于比较治疗组与对照组的时间事件终点。复合终点可以同时考虑多个时间事件终点。通常,仅对患者的第一个发生事件的时间进行分析。然而,一个人可能会经历不止一次非致命事件。将所有观察到的事件纳入分析可以提高统计效能,并更全面地了解疾病。因此,需要使用分析复发性事件的方法。一个挑战是,属于复合终点的不同事件类型通常具有不同的临床相关性。在这种情况下,根据其临床相关性对事件类型进行加权是一种选择。已经提出了用于复合时间事件终点的不同基于权重的方法。到目前为止,这些方法之间还没有进行系统的比较。

方法

在这项工作中,我们在考虑非致命和致命事件具有不同临床相关性的复发性事件背景下,对三种用于加权复合终点的方法进行了系统比较。我们考虑了 Wei 和 Lachin 提出的方法的扩展、Rauch 等人提出的方法和 Bakal 等人提出的方法。比较是基于模拟研究和临床研究示例进行的。

结果

对于所有三种方法,都有封闭公式的检验统计量。Wei-Lachin 方法和 Rauch 等人的方法在均方误差方面表现相似。对于 Wei 和 Lachin 的方法,提供了置信区间。Bakal 等人的方法与可量化的估计量无关。不同方法的相关权重作用于不同的水平,即因果风险比或事件计数。

结论

提供的比较和模拟可以帮助指导应用研究人员选择适当的方法来分析具有不同临床相关性的(复发性)事件的复合终点。当复合效应与时间无关时,推荐使用 Wei 和 Lachin 以及 Rauch 等人的方法。Bakal 等人的方法应谨慎使用。

相似文献

1
Weighted composite time to event endpoints with recurrent events: comparison of three analytical approaches.具有复发性事件的加权复合时间事件终点:三种分析方法的比较。
BMC Med Res Methodol. 2022 Feb 5;22(1):38. doi: 10.1186/s12874-022-01511-1.
2
A systematic comparison of recurrent event models for application to composite endpoints.系统比较应用于复合终点的复发事件模型。
BMC Med Res Methodol. 2018 Jan 4;18(1):2. doi: 10.1186/s12874-017-0462-x.
3
Introducing a new estimator and test for the weighted all-cause hazard ratio.引入一种新的加权全因风险比估计量和检验方法。
BMC Med Res Methodol. 2019 Jun 11;19(1):118. doi: 10.1186/s12874-019-0765-1.
4
A weighted combined effect measure for the analysis of a composite time-to-first-event endpoint with components of different clinical relevance.用于分析具有不同临床相关性组成部分的复合首次事件时间终点的加权组合效应度量。
Stat Med. 2018 Feb 28;37(5):749-767. doi: 10.1002/sim.7531. Epub 2017 Dec 4.
5
Time-to-first-event versus recurrent-event analysis: points to consider for selecting a meaningful analysis strategy in clinical trials with composite endpoints.时间至首次事件分析与复发性事件分析:在具有复合终点的临床试验中选择有意义的分析策略时需要考虑的要点。
Clin Res Cardiol. 2018 May;107(5):437-443. doi: 10.1007/s00392-018-1205-7. Epub 2018 Feb 16.
6
Application of the Wei-Lachin multivariate one-directional test to multiple event-time outcomes.将魏-拉钦多变量单向检验应用于多个事件时间结局。
Clin Trials. 2015 Dec;12(6):627-33. doi: 10.1177/1740774515601027. Epub 2015 Sep 2.
7
Systematic comparison of approaches to analyze clustered competing risks data.系统比较分析聚集性竞争风险数据的方法。
BMC Med Res Methodol. 2023 Apr 10;23(1):86. doi: 10.1186/s12874-023-01908-6.
8
A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components.一种用于分析复合终点的胜率的广义解析解,该解析解考虑了各组成部分之间的临床重要性顺序。
Pharm Stat. 2016 Sep;15(5):430-7. doi: 10.1002/pst.1763. Epub 2016 Aug 2.
9
The Average Hazard Ratio - A Good Effect Measure for Time-to-event Endpoints when the Proportional Hazard Assumption is Violated?平均风险比——当比例风险假设不成立时,用于事件发生时间终点的良好效应量度?
Methods Inf Med. 2018 May;57(3):89-100. doi: 10.3414/ME17-01-0058. Epub 2018 May 2.
10
Impact of weighted composite compared to traditional composite endpoints for the design of randomized controlled trials.与传统复合终点相比,加权复合终点对随机对照试验设计的影响。
Stat Methods Med Res. 2015 Dec;24(6):980-8. doi: 10.1177/0962280211436004. Epub 2012 Jan 24.

引用本文的文献

1
Expanding the use and interpretation of patient-centric cardiovascular clinical trial endpoints.扩大以患者为中心的心血管临床试验终点的应用和解读。
J Clin Transl Sci. 2025 Jul 3;9(1):e151. doi: 10.1017/cts.2025.10054. eCollection 2025.
2
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression.帕金森进展标志物倡议:一种基于里程碑的策略,用于监测帕金森病的进展。
J Parkinsons Dis. 2023;13(6):899-916. doi: 10.3233/JPD-223433.
3
Making Sense of Composite Endpoints in Clinical Research.理解临床研究中的复合终点
J Clin Med. 2023 Jun 29;12(13):4371. doi: 10.3390/jcm12134371.
4
The empirical estimate of the survival and variance using a weighted composite endpoint.使用加权复合终点对生存和方差进行经验估计。
BMC Med Res Methodol. 2023 Feb 6;23(1):35. doi: 10.1186/s12874-023-01857-0.

本文引用的文献

1
Introducing a new estimator and test for the weighted all-cause hazard ratio.引入一种新的加权全因风险比估计量和检验方法。
BMC Med Res Methodol. 2019 Jun 11;19(1):118. doi: 10.1186/s12874-019-0765-1.
2
A systematic comparison of recurrent event models for application to composite endpoints.系统比较应用于复合终点的复发事件模型。
BMC Med Res Methodol. 2018 Jan 4;18(1):2. doi: 10.1186/s12874-017-0462-x.
3
A weighted combined effect measure for the analysis of a composite time-to-first-event endpoint with components of different clinical relevance.用于分析具有不同临床相关性组成部分的复合首次事件时间终点的加权组合效应度量。
Stat Med. 2018 Feb 28;37(5):749-767. doi: 10.1002/sim.7531. Epub 2017 Dec 4.
4
An extension of generalized pairwise comparisons for prioritized outcomes in the presence of censoring.存在删失时优先结局的广义成对比较的扩展。
Stat Methods Med Res. 2018 Apr;27(4):1230-1239. doi: 10.1177/0962280216658320. Epub 2016 Aug 2.
5
Large sample inference for a win ratio analysis of a composite outcome based on prioritized components.基于优先排序组件的复合结局胜率分析的大样本推断
Biostatistics. 2016 Jan;17(1):178-87. doi: 10.1093/biostatistics/kxv032. Epub 2015 Sep 8.
6
Application of the Wei-Lachin multivariate one-directional test to multiple event-time outcomes.将魏-拉钦多变量单向检验应用于多个事件时间结局。
Clin Trials. 2015 Dec;12(6):627-33. doi: 10.1177/1740774515601027. Epub 2015 Sep 2.
7
Novel approaches to composite endpoints in clinical trials.临床试验中复合终点的新方法。
EuroIntervention. 2015 May;11(1):122-4. doi: 10.4244/EIJV11I1A22.
8
Simulating recurrent event data with hazard functions defined on a total time scale.使用在总时间尺度上定义的风险函数模拟复发事件数据。
BMC Med Res Methodol. 2015 Mar 8;15:16. doi: 10.1186/s12874-015-0005-2.
9
Multivariate frailty models for two types of recurrent events with a dependent terminal event: application to breast cancer data.具有相依终末事件的两类复发事件的多变量脆弱性模型:应用于乳腺癌数据
Biom J. 2013 Nov;55(6):866-84. doi: 10.1002/bimj.201200196. Epub 2013 Aug 9.
10
Planning and evaluating clinical trials with composite time-to-first-event endpoints in a competing risk framework.在竞争风险框架下规划和评估具有复合首次事件时间终点的临床试验。
Stat Med. 2013 Sep 20;32(21):3595-608. doi: 10.1002/sim.5798. Epub 2013 Apr 2.